Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
OcuTerra Therapeutics
Biotech
Phase 2 fail sends OcuTerra's eye drop dreams down the drain
OcuTerra's eye drops failed to improve disease severity or progression in a phase 2 diabetic retinopathy trial.
Gabrielle Masson
Mar 14, 2024 9:15am
Fierce Biotech launches layoff tracker—Chutes and Ladders
Apr 8, 2022 9:30am
With ex-Allergan CEO on board, OcuTerra nabs $35M for eye drops
Nov 9, 2021 6:00am
